NCT06034860 2024-11-01Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesMolecular Templates, Inc.Phase 1 Terminated15 enrolled
NCT03278626 2022-03-28Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell CarcinomaNYU Langone HealthPhase 1/2 Terminated12 enrolled 8 charts